These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3477535)

  • 1. Mammary steroidogenesis: therapeutic implications.
    Miller WR; O'Neill J
    Int J Rad Appl Instrum B; 1987; 14(4):369-75. PubMed ID: 3477535
    [No Abstract]   [Full Text] [Related]  

  • 2. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
    Brodie AM; Santen RJ
    Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of aromatase inhibitors in the treatment of breast cancer.
    Manni A; Santen RJ
    Cancer Treat Res; 1988; 39():67-81. PubMed ID: 2908609
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
    Lønning PE; Dowsett M; Powles TJ
    J Steroid Biochem; 1990 Mar; 35(3-4):355-66. PubMed ID: 2139151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase-inhibitors of the androstenedione-type activate the 17 beta-hydroxysteroid-dehydrogenase in the rat testis tissue suspension model.
    Schröder H; Ziegler M; el Etreby MF
    J Steroid Biochem; 1988 Oct; 31(4B):685-90. PubMed ID: 3199812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase inhibition and its pharmacologic implications.
    Brodie AM
    Biochem Pharmacol; 1985 Sep; 34(18):3213-9. PubMed ID: 3899122
    [No Abstract]   [Full Text] [Related]  

  • 9. 17 Beta-hydroxysteroid dehydrogenase and aromatase activity in breast fat from women with benign and malignant breast tumours.
    Beranek PA; Folkerd EJ; Ghilchik MW; James VH
    Clin Endocrinol (Oxf); 1984 Feb; 20(2):205-12. PubMed ID: 6325047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors.
    Häusler A; Schenkel L; Krähenbühl C; Monnet G; Bhatnagar AS
    J Steroid Biochem; 1989 Jul; 33(1):125-31. PubMed ID: 2527324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase in human breast carcinoma.
    Perel E; Blackstein ME; Killinger DW
    Cancer Res; 1982 Aug; 42(8 Suppl):3369s-3372s. PubMed ID: 7083202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening.
    Kitawaki J; Kim T; Kanno H; Noguchi T; Yamamoto T; Okada H
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):667-70. PubMed ID: 8476780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological significance of aromatase activity in human breast tumors.
    Tilson-Mallett N; Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1125-8. PubMed ID: 6630410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of androgen aromatization in human breast cancer.
    Abul-Hajj YJ
    J Steroid Biochem; 1980 Dec; 13(12):1395-400. PubMed ID: 7464118
    [No Abstract]   [Full Text] [Related]  

  • 16. Oestrogen-synthesising enzymes and breast cancer.
    Kulendran M; Salhab M; Mokbel K
    Anticancer Res; 2009 Apr; 29(4):1095-109. PubMed ID: 19414351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women.
    Vermeulen A; Deslypere JP; Paridaens R; Leclercq G; Roy F; Heuson JC
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):515-25. PubMed ID: 3015631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
    Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of aromatase in breast tumors.
    Reed MJ
    Breast Cancer Res Treat; 1994; 30(1):7-17. PubMed ID: 7949206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracrine mechanism of estrogen synthesis in breast cancer.
    Suzuki T; Moriya T; Ishida T; Ohuchi N; Sasano H
    Biomed Pharmacother; 2003 Dec; 57(10):460-2. PubMed ID: 14637389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.